Back to results
US 2001/0056185 A1Published application
C3A receptor ligands
OwnerDennis Leeinventor
Life of this patent
Estimating the term…
Abstract
Novel C3A ligands are provided. Methods of using the present compounds to treat immune and inflammation disease are also provided.
Claims15
A compound according to Formula (I):
- 3
- wherein:
- A represents C1-4 alkylene, optionally substituted by C1-4 alkyl or aryl;
- or A forms a 5-8 membered fused aliphatic ring with the adjacent phenyl ring;
- m is an integer from 1 to 3;
- each R1 is independently selected form the group consisting of halo, C1-4 alkyl, methanesulfonyl, alkoxy, nitrile, dimethylamine, methylenedioxy and CF3;
- R2 is selected from the group consisting of optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted phenyl, optionally substituted alkylsulfonyl, heteroarylsufonyl, optionally substituted phenylalkylaminocarbonyl, phenylaminocarbonyl, optionally substituted phenylalkyl, optionally substituted phenylsulfonyl, optionally substituted phenylalkylsulfonyl, optionally substituted naphthylalkylsulfonyl, heteroaryl carbonyl, heteroarylalkanoyl, optionally substituted alkylcarbonyl, optionally substituted phenylcarbonyl, and optionally substituted phenylalkylcarbonyl;
- wherein any substituents are selected from the group consisting of acyl, amide, C1-4 alkyl, halo, methylenedioxy, phenoxy and alkoxy;
- or R2 forms a 5-8 membered ring with A;
- or R2 forms a 4 to 7 membered ring with the carbon atom having the R4 substituent;
- R3 represents hydrogen or methyl;
- and
- R4 represents hydrogen or methyl.
10 more elements
[3,5-Dichlorobenzylamino-N-(3-phenylpropionyl)]acetylarginine.
Dependencies are inferred from the claim text.